James Irvin Healy is an American businessperson who has been at the head of 5 different companies and holds the position of Chairman for Y-mAbs Therapeutics, Inc., Chairman of CinCor Pharma, Inc. and Managing Partner at Sofinnova Investments, Inc., Managing Partner at Sofinnova Investments, Inc. (Investment Management), Managing General Partner at Sofinnova Venture Partners VII LP, Managing Partner at Sofinnova Management VI LLC and Managing Partner at Sofinnova Management VII LLC (which are all subsidiaries of Sofinnova Investments, Inc.).

He is also Managing General Partner at Sofinnova Venture Partners VII LP, Managing Partner at Sofinnova Management VI LLC and Managing Partner at Sofinnova Management VII LLC and on the board of 7 other companies.

In the past Dr. Healy was Independent Director at Humanigen, Inc., Manager at ISTA Pharmaceuticals, Inc., Associate for Sanderling Ventures, Chairman at Hyperion Therapeutics, Inc., Principal at Bayer Pharmaceuticals Corp., Principal at Lawrence Berkeley National Laboratory and Director at PregLem SA.

He received an undergraduate degree from the University of California, Berkeley and a doctorate from Stanford University School of Medicine.